Gyorgy Bagdy, Marton Graf, Zsuzsanna E. Anheuer, Edit A. Modos and Sandor Kantor
|
|
- Morgan McBride
- 5 years ago
- Views:
Transcription
1 International Journal of Neuropsychopharmacology (2001), 4, Copyright 2001 CINP DOI: S Anxiety-like effects induced by acute fluoxetine, sertraline or m-cpp treatment are reversed by pretreatment with the 5-HT 2C antagonist SB but not the 5-HT 1A antagonist WAY BRIEF REPORT Gyorgy Bagdy, Marton Graf, Zsuzsanna E. Anheuer, Edit A. Modos and Sandor Kantor Laboratory of Neurochemistry and Experimental Medicine, and Department of Neurology, Faculty of Health Sciences, Semmelweis University, National Institute of Psychiatry and Neurology, Budapest, Huvosvolgyi ut 116, H-1021, Hungary Abstract The possible role of 5-HT and 5-HT s in the anxiety induced by fear, acute treatment with SSRI A C antidepressants or the 5-HT agonist m-cpp were tested in the social interaction anxiety test in male Sprague Dawley rats. Fluoxetine ( mg kg, i.p.), sertraline (15 mg kg, i.p.) and m-cpp ( mg kg, i.p.) all had an anxiogenic-like profile (decrease in time of total social interaction and increase in self-grooming compared to vehicle) under low-light, familiar arena test conditions. All these effects were reversed by pretreatment with the highly subtype-selective 5-HT antagonist, SB at doses of either 0 05 C or 0 2 mg kg, i.p. In contrast, the selective 5-HT antagonist WAY (0 05 and 0 2 mg kg, A s.c.) failed to reverse SSRI-induced decrease in time of total social interaction, further, it augmented selfgrooming response. SB (0 2 mg kg) and WAY (0 05 and 0 2 mg kg) reversed hypolocomotion caused by the SSRI antidepressants. SB , tested alone against vehicle under high-light, unfamiliar arena test conditions associated with fear, caused significant anxiolysis at 0 2 mg kg and higher doses. These results suggest that increased anxiety in rodents, and possibly, also in humans (e.g. agitation or jitteriness after SSRIs and panic after m-cpp), caused by acute administration of SSRI antidepressants or m-cpp, are mediated by activation of 5-HT s. Blockade of 5-HT autos may exacerbate certain C A acute adverse effects of SSRI antidepressants. Both 5-HT and 5-HT s are involved in the SSRIinduced decrease in locomotor activity. In addition, our studies confirm data that subtype-selective 5-HT C A C antagonists have strong anxiolytic actions. Received 1 April 2001; Reviewed 31 May 2001; Revised 5 August 2001; Accepted 19 August 2001 Key words: Anxiety, 5-HT, 5-HT, 5-HT, locomotor activity, m-cpp, SSRI C A antidepressant. Introduction SSRI antidepressants are therapeutically active in several anxiety disorders (Nutt and Glue, 1989; Papp, 1999; Westenberg and Den Boer, 1993). Clinically, the effect of these agents are characterized by delayed onset with the likelihood of initial exacerbation, e.g. agitation or jitteriness, especially in panic disorder patients, and that Address for correspondence: Dr G. Bagdy, Laboratory of Neurochemistry and Experimental Medicine, and Department of Neurology, Faculty of Health Sciences, Semmelweis University, National Institute of Psychiatry and Neurology, Budapest, Huvosvolgyi ut 116, H-1021, Hungary. Tel.: Fax: bag13638 helka.iif.hu may cause a decrease in treatment acceptance (Nutt and Glue, 1989; Papp, 1999; Pohl et al., 1988; Westenberg and Den Boer, 1993). In animal models of anxiety SSRI antidepressants are, in general, characterized by an anxiogenic-like profile after acute administration (Griebel, 1995; Handley et al., 1993). A transient anxiogenic-like effect of fluoxetine in the social interaction test that disappeared after chronic treatment was described by our group in earlier studies (To and Bagdy 1999; To et al., 1999). Pharmacological characterization of the effects of the 5-HT agonist m-chlorophenylpiperazine (m-cpp) led to the hypothesis that activation of 5-HT C s may mediate anxiety in humans and rodents although pharmacological tools used in these studies were not able to differentiate between 5-HT B and 5-HT C s
2 400 G. Bagdy et al. (a) (b) Figure 1. Effects of different doses of (a) fluoxetine ( mg kg, i.p.) and (b) m-cpp ( mg kg, i.p.) in the social interaction anxiety test under low-light, familiar arena conditions. Significant effects (p 0 05) compared to vehicle are denoted by *. (Bagdy, 1996, 1998; Bagdy et al., 1992; Bristow et al., 2000; Kennett et al., 1989; Murphy et al., 1991). Furthermore, the role of either 5-HT, namely 5-HT A, 5-HT A,5-HT B, and 5-HT C s, or other mechanisms, e.g. noradrenergic and neuropeptide systems have been suggested in acute and or chronic effects of SSRI antidepressants (Bristow et al., 2000; Dekeyne et al., 2000; Handley et al., 1993; Kennett et al., 1994; Lerer et al., 1999; Matto et al., 1996; Quested et al., 1997; Szabo et al., 2000; To and Bagdy 1999; To et al., 1999), but only one study used a 5-HT C subtype-selective antagonist (Dekeyne et al., 2000). To study the possible role of 5-HT A and 5-HT C s in acute SSRI administration-induced anxiety, WAY , a subtypeselective 5-HT A antagonist (Fletcher et al., 1996; Griebel, 1999) and SB , a subtype-selective 5-HT C antagonist (Kennett et al., 1997) were used as a pretreatment before administration of SSRI antidepressants. In addition to social interaction another measure of anxiety, self-grooming, and the anxiolytic-like actions of SB per se were also tested. Method All procedures used in this study were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals. The protocol of the study was approved by the local Ethical Committee. Male Sprague
3 5-HT C s mediate SSRI-induced anxiety 401 (a) (b) Figure 2. Effects of fluoxetine (5 0 mg kg, i.p.) after pretreatment with (a) SB (0 05 and 0 2 mg kg, i.p.), (b) WAY (0 05 and 0 2 mg kg s.c.) or vehicle in the social interaction anxiety test under low-light, familiar arena conditions. Significant effects (p 0 05) compared to vehicle vehicle are denoted by *; significant effects (p 0 05) of fluoxetine compared to the antagonist vehicle are denoted by. Dawley rats ( g, Crl: CDRBR, Charles River, Hungary), were used in the studies. The animals (4 per cage) were kept under standard conditions, with standard food (CRLT AM, Charles River, Hungary) and water freely available. The temperature was 21 1 C, the 12 h light dark cycle started at 06:00 hours. The social interaction test was performed as described previously (To and Bagdy, 1999). Rats were housed in a room adjacent to the testing room at least for 2 wk before the tests. The animals were randomly assigned to treatments. In the low-light (5 lx), familiar arena conditions animals were individually pre-exposed to the test box and the injections three times on days preceding the test. In the high-light (300 lx), unfamiliar arena conditions animals were not habituated to the test box. Rats were tested for social interaction with an unknown test partner that did not differ by more than 15 g in weight. At the end of each test the box was thoroughly wiped with detergent and dried to remove odours. The animals were tested in a random order between 09:00 and 13:00 hours in an
4 402 G. Bagdy et al. adjacent room for 7 5 min. The evenly illuminated box ( cm), was marked in 10 cm compartments by lines on the floor. The behaviour of animals was recorded on videotape. It was scored later by a person unaware of the drug treatment as described earlier (To and Bagdy, 1999). The following behaviours were included in total social interaction: sniffing partner, anogenital sniffing, peaceful following, grooming partner, crawling under, climbing over, chasing, aggressive grooming, dominant posture, submissive posture, biting, boxing, kicking, pushing, wrestling. Rearing, crossing of lines and self-grooming were also scored. SB (6-chloro-5-methyl-1-[(2-[2-methylpyrid- 3-yloxy]pyrid-5-yl)carbamoyl]indoline dihydrochloride, Sigma-Aldrich, Budapest, Hungary), sertraline hydrochloride and fluoxetine hydrochloride (both kindly donated by EGIS Pharmaceuticals Ltd, Budapest, Hungary) were dissolved in 10% solution of 2-hydroxypropylβ-cyclodextrin (Research Biochemicals International, Natick, MA, USA). WAY maleate (N-[2- [4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl cyclohexanecarboxamide maleate, Research Biochemicals International) and m-cpp (meta-chlorophenylpiperazine hydrochloride, Research Biochemicals International), were dissolved in physiological saline. WAY was administered s.c., all other drugs i.p., in a volume of 1 ml kg. SB was administered 5 min before the SSRI antidepressants, WAY min before the SSRI antidepressants or m-cpp, which was administered 20 min before the test. The data were analysed using one- or two-way ANOVA followed by Tukey Kramer and Kruskal Wallis tests followed by the Mann Whitney rank sum test (Super ANOVA and StatViewSE Graph, Abacus Concepts, Berkeley, CA, USA). Each treatment group consisted of animals that is, 5 7 pairs of rats. Each rat was tested only once. Data on the figures and in the text are expressed as mean S.E.M. Results Fluoxetine (Figure 1a; mg kg, i.p.) and m-cpp (Figure 1b; mg kg, i.p.) caused dose-dependent decrease in time of total social interaction [F(3,42) 7 68, p and F(3,36) 11 01, p for fluoxetine and m-cpp, respectively], increase in self-grooming and decrease in line crossings (Figure 1a, b). Minimal effective doses for time of total social interaction were 5 0 and 0 5 mg kg, for fluoxetine and m-cpp, respectively. At these doses fluoxetine, but not m-cpp, caused a significant decrease in the number of line crossings. The dose response curves for self-grooming were clearly different, Figure 3. Effects of sertraline (15 mg kg, i.p.) after pretreatment with SB (0 05 and 0 2 mg kg, i.p.) or vehicle in the social interaction anxiety test under low-light, familiar arena conditions. Significant effects (p 0 05) compared to vehicle vehicle are denoted by *; significant effects (p 0 05) of sertraline compared to the antagonist vehicle are denoted by. namely, a biphasic response was found for m-cpp but not for fluoxetine. Pretreatment with SB (0 05 and 0 2 mg kg, i.p.) significantly reversed effects of fluoxetine (Figure 2a) and sertraline (Figure 3) on time of total social interaction [F(2,68) 6 14, p 0 01 and F(2,60) 7 19, p 0 01 for pretreatment treatment interaction for fluoxetine and sertraline, respectively]. Effect of m-cpp (0 5 mg kg,
5 5-HT C s mediate SSRI-induced anxiety 403 Figure 4. Effects of m-cpp (0 5 mg kg, i.p.) after pretreatment with SB (0 05 mg kg, i.p.) or vehicle in the social interaction anxiety test under low-light, familiar arena conditions. Significant effects (p 0 05) compared to vehicle vehicle are denoted by *. i.p.) on time of total social interaction was also significantly reversed by pretreatment with SB [Figure 4; pretreatment treatment interaction, F(1,36) 12 64, p 0 01]. SB also reversed other effects, thus, self-grooming and decrease in line crossings induced by fluoxetine (Figure 2a) and sertraline (Figure 3) and selfgrooming induced by m-cpp (Figure 4), but the dose response effects of SB on the various parameters were different. Anxiety-related effects, like social in- Figure 5. Effects of different doses of SB ( mg kg, i.p.) in the social interaction anxiety test under high-light, unfamiliar arena conditions. Significant effects (p 0 05) compared to vehicle are denoted by *. teraction and self-grooming responses, were reversed by 0 05 mg kg of SB , but a higher dose was needed for the reversal of hypolocomotion. Pretreatment with WAY (Figure 2b; 0 05 and 0 2 mg kg, s.c.) failed to reverse the effects of fluoxetine on time of total social interaction or self grooming [pretreatment treatment interactions, F(2,68) 0 71, p 0 49 and F(2,68) 0 37, p 0 69, for the two parameters, respectively]. Even more, WAY alone slightly increased self-grooming, and, as a pretreatment, it augmented self-grooming response caused by fluoxetine [Figure 2b; pretreatment effect, F(2,68) 3 30, p 0 05]. In contrast, it reversed the effect of fluoxetine on line crossings very efficiently [Figure 2b; pretreatment treatment interaction, F(2,68) 5 81, p 0 005]. WAY-
6 404 G. Bagdy et al alone did not have any effect on time of total social interaction or line crossings (Figure 2b). Possible anxiolytic effects of SB alone (Figure 5; mg kg, i.p.) were tested in separate experiments under high-light, unfamiliar arena conditions. SB had significant effects on time of total social interaction and self-grooming. The minimal effective dose for both social interaction and self-grooming was 0 2 mg kg. Locomotor activity was not significantly altered, although a strong trend, a 41% increase was found in the number of line crossings at 0 5 mg kg SB compared to vehicle (Figure 5). Discussion Anxiogenic-like effect of fluoxetine (Bristow et al., 2000; Griebel, 1995; To and Bagdy 1999; To et al., 1999) and citalopram (Dekeyne et al., 2000) in the social interaction test was described in earlier studies. Acute administration of these compounds caused significant decrease in the time of total social interaction and fluoxetine caused also a decrease in the number of line crossings, and an increase in time of self-grooming (G. Bagdy, Z. E. Anheuer and S. Kantor, personal communication; Bristow et al., 2000; Dekeyne et al., 2000; To and Bagdy 1999; To et al., 1999). Under lowlight, familiar arena conditions the surrounding is comfortable for the animals, and thus, basal anxiety is low, so anxiogenic compounds, including, e.g. corticotropinreleasing hormone (CRH) or m-cpp efficiently alter parameters like social interaction (File and Hyde, 1978; Guy and Gardner, 1985; Kantor et al., 2000; Kennett et al., 1989; To et al., 1999) or self-grooming (Dunn and File, 1987; Kantor et al., 2000; To et al., 1999). The number of line crossings, a measure of locomotor activity, is decreased by some, e.g. cholecystokinin (CCK) or higher doses of m-cpp, but not all compounds that increase anxiety (File and Hyde, 1978; Guy and Gardner, 1985; Kennett et al., 1989; To and Bagdy 1999). Anxiogenic action of SSRI antidepressants is also supported by data that fluoxetine caused significant c-fos-like immunoreactivity in the central nucleus of amygdala, and paraventricular nucleus and increased ACTH and corticosterone secretion (Gibbs and Vale, 1983; Overstreet et al., 2000). The 5-HT family consists of three subtypes, namely, the 5-HT, the 5-HT and the 5-HT (formerly A B C 5-HT ), and several antagonists, like ritanserin C has similar affinity for all three subtypes (Bonhaus et al., 1997). SB , the first subtype-selective 5-HT C antagonist, has very high affinity (pk i 9 0) for the cloned human 5-HT and has over 100- and C 158-fold selectivity over the cloned human 5-HT and 5- A HT s (Kennett et al., 1997). Furthermore, it has B at least 100-fold selectivity for this over all other s tested (Kennett et al., 1997). The affinities of m- CPP for these subtypes are 5-HT 5-HT 5-HT B C A (Bonhaus et al., 1997; Murphy et al., 1991), but functional characterization on recombinant human s showed that, compared to 5-HT, m-cpp has 65, 24 and 22% relative efficacies on 5-HT, 5-HT and 5-HT C B A s, respectively (Porter et al., 1999). SB reversed the actions of SSRI antidepressants and m-cpp very efficiently in our study; in the dose of 0 05 mg kg it reversed decrease of social interaction and increase in selfgrooming caused by all compounds tested. These data, together with a recently published study of Dekeyne et al. (2000), where SB effectively reversed anxiogenic action of citalopram, strongly suggest that 5-HT C s mediate the anxiogenic actions of SSRI antidepressants caused by increased synaptic 5-HT concentration. SB alone failed to alter anxiety-related behaviours, namely, time of total social interaction and self-grooming, but pretreatment with this compound significantly reversed these effects of SSRI antidepressants and m-cpp, and in addition, hypolocomotion caused by fluoxetine and sertraline under low-light, familiar arena conditions. Because of the -binding profile of this compound, these data suggest that SSRIs and m-cpp mediate anxiogenic responses by activation of 5-HT C s. However, other explanations might also be possible, thus first, the effect of the compounds on the locomotion may confound the interpretation of the data, secondly, the anxiolytic effect of SB per se may lead to a false conclusion. To discuss the first question, our data show that decreases in locomotion caused by fluoxetine are, in some cases parallel to its effect on total social interaction, that might suggest that the decrease in social interaction may be caused by the effects on locomotion. However, these effects showed clear dissociation in the case of m-cpp and citalopram, thus, m-cpp failed to decrease locomotion at the doses of 0 5 mg kg, but it caused significant decrease on time of total social interaction. A similar dissociation was found in the case of citalopram (G. Bagdy, Z. E. Anheuer and S. Kantor, personal communication; Dekeyne et al., 2000). The efficacies of SB on SSRI-induced social interaction and locomotion were also dissociated, namely, anxiety-like effects were reversed by 0 05 mg kg SB , while higher doses of the compound were needed for the reversal of hypolocomotion (see Results). In addition, WAY completely reversed hypolocomotion caused by fluoxetine but it failed to reverse the decrease in social interaction. Thus, the decrease and reversal in social interaction cannot be considered as a secondary
7 5-HT C s mediate SSRI-induced anxiety 405 effect of locomotion. Furthermore, in addition to social interaction, we used another measure of anxiety, namely self-grooming. This stereotype behaviour is increased by aversive stimuli and anxiogenic compounds like CRH or m-cpp measured either in the social interaction test or in single cages (Bagdy et al. 1992; Dunn and File, 1987; Kantor et al., 2000; To et al., 1999). Conversely, it is attenuated by anxiolytic compounds under high anxiety conditions. Under certain conditions, this parameter is a more sensitive and less variable measure than time of total social interaction (Dunn and File, 1987; Kantor et al., 2000; To et al., 1999). For example, WAY pretreatment enhanced self-grooming response but not social interaction caused by fluoxetine in this study, and the minimal effective dose for fluoxetine was lower for self-grooming than for social interaction (see Results). It is likely that augmentation of this stereotypical behaviour by WAY is caused by the enhancement of the effect of fluoxetine on extracellular 5-HT, as was shown in microdialysis studies (Malagie et al., 1996). It has been suggested that m-cpp-induced self-grooming is mediated by 5-HT C (formerly 5-HT C ) s, although subtype-selective 5-HT C antagonists have not been used, and neuropeptides synthesized by the hypothalamic paraventricular nucleus (Bagdy and Makara, 1995; Bagdy et al., 1992). m-cpp causes significant increase of this response at low doses where absolutely no locomotion effect can be observed (Bagdy et al., 1992). Dose-dependence of self-grooming and locomotion response of m-cpp were also dissociated in this study. Thus, anxiety-like responses of SSRIs and m-cpp, and anxiolytic effects of SB cannot be explained on the basis of activity changes. A similar conclusion was drawn also by Bristow et al. (2000) who measured anxiety and locomotion after fluoxetine treatment. To address the second question, namely, that the anxiolytic effect of SB per se may lead to a false conclusion, we performed an experiment with SB at high-light, unfamiliar arena conditions. Although at low-light, familiar arena conditions, where SB reversed the effects of m-cpp and the SSRIs, the effects of SB alone were not significant, additional experiments were necessary, because under low-light, familiar arena conditions anxiolytic compounds per se show weak effects, but their anxiolytic-like effects are enhanced under conditions where the animals sense more fear (File and Hyde, 1978; Guy and Gardner, 1985; Kantor et al., 2000). Under high light, unfamiliar arena conditions SB alone caused dose-dependent anxiolytic-like activity. Significant effect was found, however, only at 0 2 and 0 5 but not at 0 05 mg kg. This finding is similar to that described by Kennett et al. (1997), despite the fact that we used a 2-fold shorter observation period, similar to that also used by other groups (File and Hyde, 1978; Guy and Gardner, 1985). In contrast, SB completely reversed social interaction and self-grooming effects of the SSRIs and m-cpp at the dose of 0 05 mg kg, thus, this latter effect can not be explained by the anxiolytic action of this compound. The anxiogenic-like effects of fluoxetine were abolished after chronic treatment (Bristow et al., 2000; To and Bagdy, 1999; To et al., 1999). This finding is in parallel with the clinical and experimental data obtained with chronic SSRI treatment (Handley et al., 1993; Lightowler et al., 1994; Nutt and Glue, 1989; Westenberg and Den Boer, 1993). There is a higher activation of postsynaptic s by the excess extracellular 5-HT produced by chronic, compared to acute, SSRI treatment (Artigas, 1993; Bel and Artigas 1993; Invernizzi et al., 1994). Furthermore, disappearance of fluoxetine-induced acute anxiety is accelerated by additional subchronic administration of WAY (Bristow et al., 2000). The antagonists used for characterization of s that mediate the effect of fluoxetine used in the work of Bristow et al. (2000) could not differentiate between 5- HT B and 5-HT C s. By the use of the subtypeselective SB , our data show that fluoxetineinduced anxiety is mediated by 5-HT C s. Thus, the mechanism of action of delayed attenuation of fluoxetine-induced anxiety possibly includes desensitization of 5-HT C s. This is supported also by the clinical data that m-cpp exacerbates symptoms before, but not after chronic treatment with clomipramine (Zohar et al., 1988), and m-cpp-induced neuroendocrine and hyperthermic responses are attenuated after chronic citalopram treatment (Quested et al., 1997). In rats, m-cpp-induced hypolocomotion was attenuated after chronic SSRI treatment (Kennett et al., 1994). The role of 5-HT B or 5-HT C s have been suggested in these responses of m-cpp at least in rats (Aulakh et al., 1992; Bagdy, 1996, 1998; Bagdy et al., 1989, 1992; Bristow et al., 2000; Lucki et al., 1989), and, in addition, effectiveness of SB in self-grooming and social interaction responses in this study provide further evidence for the involvement of 5-HT C s in m-cpp-induced anxiety, thus, these data support the view that desensitization of 5-HT C s is caused by chronic SSRI treatment. Fluoxetine has modest affinity for 5-HT C s (Bonhaus et al., 1997; Jenck et al., 1994; Palvimaki et al., 1996). In an in vivo functional model for 5-HT C s, however, it failed to have any significant 5-HT C antagonist action (Jenck et al., 1994). This might be explained by its 5-HT-mimetic, reuptake inhibiting effect (Jenck et al., 1994). Indeed, its affinity for the 5-HT uptake site is much higher than its affinity for the 5-HT C
8 406 G. Bagdy et al. (Palvimaki et al., 1996). The dose of fluoxetine used in this study was based on the dose response curves (Figure 1a), the dose of sertraline on the ratio of clinical doses and affinities for the 5-HT uptake sites of these compounds (Kasper et al., 1994; Palvimaki et al., 1996). An increase in serotonergic function produced by SSRI antidepressants underlies their clinical effectiveness in anxiety disorders and major depression (Artigas, 1993; Mongeau et al., 1997). Interestingly, acute increase in 5- HT neurotransmission usually increases fear and anxietylike behaviour (Griebel, 1995), although it may have also an opposite effect depending on the type of the test (Hetem et al., 1996). Increased anxiety-like behaviour was described in Fawn-Hooded rats, a strain with inherited impairment of 5-HT storage and uptake (Kantor et al., 2001). Graeff et al. (1996) suggested that at least three serotonergic pathways are involved in the regulation of anxiety, thus, separate pathways facilitate conditioned fear, inhibit inborn fight flight reactions and promote resistance to chronic, unavoidable stress. SSRIs and m- CPP increase anxiety in the social interaction test or in the elevated plus maze in rats (Griebel, 1995; Handley et al., 1993; Kantor et al., 2000; Kennett et al., 1989; To and Bagdy, 1999). Anxiogenic effects of m-cpp in clinical studies are also well known (Arato and Bagdy, 1998; Kahn and Wetzler, 1991; Murphy et al., 1991), and anxiety related transient effects of SSRI antidepressants, like agitation or jitteriness have been described (Nutt and Glue, 1989; Papp, 1999; Pohl et al., 1988; Westenberg and Den Boer, 1993). Stress hormones, like ACTH and cortisol or corticosterone are also released after acute administration of these compounds in both humans and rodents (Bagdy et al., 1989; Murphy et al., 1991). However, ritanserin, a non-subtype-selective 5-HT antagonist that reverses some effects of m-cpp, may also increase or decrease anxiety (Bagdy 1998; Guimares et al., 1997; Kahn and Wetzler, 1991). Furthermore, activation of the 5-HT C efficiently alters release of other neurotransmitters like noradrenaline, adrenaline, dopamine or glutamate (Bagdy et al., 1989; Di Matteo et al., 1999; Marcoli et al., 1998; Millan et al., 1998), and neuropeptides like CRH, oxytocin and vasopressin (Bagdy et al., 1989, 1992; Calogero et al., 1989). Some of these neurotransmitters systems may mediate anxiolytic and antidepressant activity of SSRIs. The role of CCK in SSRI-induced anxiety-like effects is supported by the data that citalopram-induced decrease in exploratory behaviour is reversed by a CCK B antagonist (Matto et al., 1996). A progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained SSRI treatment has been shown in electrophysiological studies (Szabo et al., 2000). Furthermore, CCK or CRH-induced anxiety is also decreased after chronic SSRI treatment (To and Bagdy, 1999; To et al., 1999; Van Megen et al., 1997). Thus, different anatomical pathways and other neurotransmitter neuropeptide systems and s may mediate or modulate 5-HT C -induced changes. In conclusion, our studies provide evidence that acute anxiogenic effects of SSRI antidepressants are reversed by pretreatment with low doses of the subtype-selective 5-HT C antagonist SB , and thus, they suggest that anxiety-related side-effects of acute SSRI treatment, like agitation or jitteriness, may be mediated by 5-HT C s. Acknowledgements These studies were supported by the Hungarian Research Fund Grant T020500, Ministry of Health Research Grant T , and Postdoctoral Ph.D. Fellowship Program of the Semmelweis University, Ministry of Culture and Education, Hungary. References Arato M, Bagdy G (1998). Gender difference in m-cpp challenge test in healthy volunteers. International Journal of Neuropsychopharmacology 1, Artigas F (1993). 5-HT and antidepressants: new views from microdialysis studies. Trends in Pharmacological Sciences 14, 262. Aulakh CS, Hill JL, Murphy DL (1992). Effect of various serotonin subtype selective antagonists alone and on m-cpp-induced neuroendocrine changes in rats. Journal of Pharmacology and Experimental Therapeutics 263, Bagdy G (1996). Role of the hypothalamic paraventricular nucleus in 5-HT A,5-HT A and 5-HT C -mediated oxytocin, prolactin and ACTH corticosterone responses. Behavioural Brain Research 73, Bagdy G (1998). Serotonin, anxiety, and stress hormones. Focus on 5-HT subtypes, species and gender differences. Annals of the New York Academy of Sciences 851, Bagdy G, Calogero AE, Murphy DL, Szemeredi K (1989). Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamopituitary adrenocortical axis in conscious rats. Endocrinology 125, Bagdy G, Kalogeras KT, Szemeredi K (1992). Effect of 5-HT C and 5-HT stimulation on excessive grooming, penile erection, and plasma oxytocin concentrations. European Journal of Pharmacology 229, Bagdy G, Makara GB (1995). Paraventricular nucleus controls 5-HT -mediated corticosterone and prolactin but not oxytocin and penile erection responses. European Journal of Pharmacology 275,
9 5-HT C s mediate SSRI-induced anxiety 407 Bel N, Artigas F (1993). Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15, Bonhaus DW, Weinhardt KK, Taylor M, Desouza A, McNeeley PM, Szczepanski K, Fontana DJ, Trinh J, Rocha CL, Dawson MW, Flippin LA, Eglen RM (1997). RS : a novel high affinity and selective, 5-HT C antagonist. Neuropharmacology 36, Bristow LJ, O Connor D, Watts R, Duxon MS, Hutson PH (2000). Evidence for accelerated desensitisation of 5-HT C s following combined treatment with fluoxetine and the 5-HT A antagonist, WAY 100,635, in the rat. Neuropharmacology 39, Calogero AE, Bernardini R, Margioris AN, Bagdy G, Gallucci WT, Munson PJ, Tamarkin L, Tomai TP, Brady L, Gold PW, Chrousos PW (1989). Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami. Peptides 10, Dekeyne A, Denorme B, Monneyron S, Millan MJ (2000). Citalopram reduces social interaction in rats by activation of serotonin (5-HT) C s. Neuropharmacology 39, Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (1999). SB , a selective serotonin C antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38, Dunn AJ, File SE (1987). Corticotropin-releasing factor has an anxiogenic action in the social interaction test. Hormones and Behavior 21, File SE, Hyde JRG (1978). Can social interaction be used to measure anxiety? British Journal of Pharmacology 62, Fletcher A, Froster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJP, Childs KJ, Middlefell VC, Lanfumay L, Corradetti R, Laporte A-M, Gozlan H, Hamon M, Dourish CT (1996). Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY , a potent, selective and silent 5-HT A antagonist. Behavioural Brain Research 73, Gibbs DM, Vale W (1983). Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into the hypophyseal portal blood. Brain Research 280, Graeff FG, Guimeras TS, De Andrade TG (1996). Role of 5-HT in stress, anxiety and depression. Pharmacology, Biochemistry and Behavior 54, Griebel G (1995). 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacology and Therapeutics 65, Griebel G (1999). 5-HT A blockers as potential drug candidates for the treatment of anxiety disorders. Drug News and Perspectives 12, Guimaraes FS, Mbaya PS, Deakin JF (1997). Ritanserin facilitates anxiety in a stimulated public-speaking paradigm. Journal of Psychopharmacology 11, Guy AP, Gardner CR (1985). Pharmacological characterization of a modified social interaction model of anxiety in the rat. Neuropsychobiology 13, Handley SL, McBlane JW, Critchley MAE, Njung e K (1993). Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. Behavioural Brain Research 58, Hetem LA, de Souza CJ, Guimaraes ES, Zuardi AW, Graeff FG (1996). Effect of d-fenfluramine on human experimental anxiety. Psychopharmacology 127, Invernizzi R, Bramante M, Samanin R (1994). Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT A s. European Journal of Pharmacology 260, Jenck F, Moreau J, Mutel V, Martin JR (1994). Brain 5-HT C s and antidepressants. Progress in Neuropsychopharmacology and Biological Psychiatry 18, Kahn RS, Wetzler S (1991). m-chlorophenylpiperazine as a probe of serotonin function. Biological Psychiatry 30, Kantor S, Anheuer ZE, Bagdy G (2000). High social anxiety and low aggression in Fawn-Hooded rats. Physiology and Behavior 71, Kantor S, Graf M, Anheuer ZE, Bagdy G (2001). Rapid desensitization of 5-HT A s in Fawn-Hooded rats after chronic fluoxetine treatment. European Neuropsychopharmacology 11, Kasper S, Ho flich G, Scholl HP, Mo ller HJ (1994). Safety and antidepressant efficacy of selective serotonin re-uptake inhibitors. Human Psychopharmacology 9, Kennett GA, Lightowler S, De Biasi V, Stevens NC, Wood MD, Tulloch IF, Blackburn TP (1994). Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT C/ B function. Neuropharmacology 33, Kennett GA, Whitton P, Shah K, Curzon G (1989). Anxiogenic-like effects of mccp and TFMPP in animal models are opposed by 5-HT C agonists. European Journal of Pharmacology 164, Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP (1997). SB242084, a selective and brain penetrant 5-HT C antagonist. Neuropharmacology 36, Lightowler S, Kennet GA, Williamson IJR, Blackburn TP, Tulloch IF (1994). Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacology, Biochemistry and Behavior 49, Lerer B, Gelfin Y, Gorfine M, Allolio B, Lesch KP, Newman ME (1999). 5-HT A function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology 20, Lucki I, Ward HR, Frazer A (1989). Effect of 1-(m-
10 408 G. Bagdy et al. chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)- piperazine on locomotor activity. Journal of Pharmacology and Experimental Therapeutics 249, Malagie I, Trillat AC, Douvier E, Anmella MC, Dessalles MC, Jacquot C, Gardier AM (1996). Regional differences in the effect of the combined treatment of WAY 100,635 and fluoxetine: an in vivo microdialysis study. Naunyn- Schmiedeberg s Archives of Pharmacology 354, Marcoli M, Maura G, Tortarolo M, Raiteri M (1998). Trazodone is a potent agonist at 5-HT C s mediating inhibition the N-methyl-D-aspartate nitric oxide cyclic GMP pathway in rat cerebellum. Journal of Pharmacology and Experimental Therapeutics 286, Matto V, Harro J, Allikmets L (1996). The effects of cholecystokinin A and B antagonists, devazepide and L , on citalopram-induced decrease of exploratory behaviour in rat. Journal of Physiology and Pharmacology 47, Millan MJ, Dekeyne A, Gobert A (1998). Serotonin (5-HT) C s tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT release in the frontal cortex in vivo. Neuropharmacology 37, Mongeau R, Blier P, De Montigny C (1997). The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Research Reviews 23, Murphy DL, Lesch KP, Aulakh CS, Pigott TA (1991). Serotonin-selective arylpiperazines with neuroendocrine, behavioural, temperature, and cardiovascular effects in humans. Pharmacological Reviews 43, Nutt DJ, Glue P (1989). Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective. Pharmacology and Therapeutics 44, Overstreet DH, Knapp DJ, Breese GR (2000). Mechanisms involved in the acute anxiogenic effects of fluoxetine. In: Serotonin: From the Molecule to the Clinic. A Serotonin Club Brain Research Bulletin Conference, Abstracts (p. 109). New Orleans, USA. Palvimaki EP, Roth BL, Majasuo H, Laakso A, Kuoppamaki M, Syvalahti E, Hietala (1996). Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT C. Psychopharmacology 126, Papp LA (1999). Anxiety Disorders: Somatic Treatment. In: Sadock BJ, Sadock VA (Eds.), Kaplan and Sadock s Comprehensive Textbook of Psychiatry (7th edn) (pp ). New York: Lippincott Williams and Wilkins. Pohl R, Yeragani VK, Balon R, Lycaki H (1988). The jitteriness syndrome in panic disorder patients treated with antidepressants. Journal of Clinical Psychiatry 49, Porter RHP, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Adams DR, Sheardown MJ (1999). Functional characterization of agonists at recombinant human 5-HT B and 5-HT C s in CHO-K1 cells. British Journal of Pharmacology 128, Quested DJ, Sargent PA, Cowen PJ (1997). SSRI treatment decreases prolactin and hyperthermic responses to mcpp. Psychopharmacology 133, Szabo ST, de Montigny C, Blier P (2000). Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors. International Journal of Neuropsychopharmacology 3, To CT, Anheuer ZE, Bagdy G (1999). Effects of acute and chronic fluoxetine treatment on CRH induced anxiety. NeuroReport 10, To CT, Bagdy G (1999). Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment. Neuropharmacology 38, Van Megen HJGM, Westenberg HGM, Den Boer JA, Slaap B, Scheepmakers A (1997). Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks. Psychopharmacology 129, Westenberg HGM, Den Boer JA (1993). Serotonin in anxiety related disorders. In: Vanhouette PM, Saxena PR, Paoletti R, Brunello N, Jackson AS (Eds.), Serotonin, from Cell Biology to Pharmacology and Therapeutics (pp ). Dordrecht: Kluwer Academic Publishers. Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL (1988). Serotonergic responsivity in obsessive compulsive disorder: effects of chronic clomipramine treatment. Archives of General Psychiatry 45,
Abstract. Introduction. R.N. Takahashi 1, O. Berton 2,3, P. Mormède 2 and F. Chaouloff 2
Brazilian Journal of Medical and Biological Research (21) 34: 675-682 Effects of diazepam and SB 26553 in SHR and Lewis rats ISSN 1-879X 675 Strain-dependent effects of diazepam and the 5-HT 2B/2C receptor
More informationLatency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT 1A receptor antagonist WAY100635
British Journal of Pharmacology (2000) 130, 1713 ± 1719 ã 2000 Macmillan Publishers Ltd All rights reserved 0007 ± 1188/00 $15.00 www.nature.com/bjp Latency to paroxetine-induced anxiolysis in the rat
More informationStudy of Agomelatine for the Reduction of Marble Buying Behavior in Brain Disorder
Research Article Study of Agomelatine for the Reduction of Marble Buying Behavior in Brain Disorder Shaily Chaudhary* 1,2 Akash Yadav 3 Nikunjana Patel 4 Indrajeet Singhvi 1 1Faculty of Pharmacy, Pacific
More informationOral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests
International Journal of Neuropsychopharmacology (2002), 5, 67 71. Copyright 2002 CINP DOI: 10.1017 S146114570200278X Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge
More informationNeurobiology of Addiction
Neurobiology of Addiction Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure Neither I
More informationAnxiolytics. What s new? Lindsey Sinclair
Anxiolytics Lindsey Sinclair David Nutt What s new? pregabalin has gained a licence for the treatment of generalized anxiety disorder new data support the use of escitalopram in several anxiety disorders
More informationEffects of tryptophan depletion on anxiety induced by simulated public speaking
Brazilian Journal of Medical and Biological Research (2000) 33: 581-587 Tryptophan depletion in public speaking ISSN 0100-879X 581 Effects of tryptophan depletion on anxiety induced by simulated public
More informationChapter 12 The Role of Serotonin-2C Receptors in the Pathophysiology of Depression
Chapter 12 The Role of Serotonin-2C Receptors in the Pathophysiology of Depression 1 2 3 Eliyahu Dremencov, Joost H.A. Folgering, Sandra Hogg, Laurence Tecott, and Thomas I.F.H. Cremers 4 5 12.1 Introduction
More informationINTRODUCTION. Neuropsychopharmacology (2007) 32, & 2007 Nature Publishing Group All rights reserved X/07 $30.00
(27) 32, 2163 2172 & 27 Nature Publishing Group All rights reserved 893-133X/7 $3. www.neuropsychopharmacology.org SB-649915-B, a Novel 5-HT 1A/B Autoreceptor Antagonist and Serotonin Reuptake Inhibitor,
More informationPHARMACODYNAMICS OF ANTIDEPRESSANTS MOOD STABILIZING AGENTS ANXIOLYTICS SEDATIVE-HYPNOTICS
PHARMACODYNAMICS OF ANTIDEPRESSANTS MOOD STABILIZING AGENTS ANXIOLYTICS SEDATIVE-HYPNOTICS Yogesh Dwivedi, Ph.D. Assistant Professor of Psychiatry and Pharmacology Psychiatric Institute Department of Psychiatry
More informationAntidepressant-Like Behavioral Effects Mediated by 5-Hydroxytryptamine 2C Receptors 1
0022-3565/00/2953-1120$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 295, No. 3 Copyright 2000 by The American Society for Pharmacology and Experimental Therapeutics 2758/861806
More informationMechanism of Action of Antidepressants
123-132_PBSumSuppl_Artigas 10/1/02 4:21 PM Page 123 Key Words: antidepressants, mechanism of action, SNRI, SSRI, venlafaxine, tricyclic antidepressants, monoamine oxidase inhibitors Mechanism of Action
More informationStephen M. Stahl ISSUE:
CNS Spectrums (2015), 20, 515 519. Cambridge University Press 2015 doi:10.1017/s1092852915000358 Part 4 Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions
More informationATTENUATION OF STRESS-INDUCED BEHAVIORAL DEFICITS BY AZADIRACHTA INDICA (NEEM): ROLE OF SEROTONIN
Pak. J. Bot., 38(1): 131-138, 26. ATTENUATION OF STRESS-INDUCED BEHAVIORAL DEFICITS BY AZADIRACHTA INDICA (NEEM): ROLE OF SEROTONIN NOREEN SAMAD, TAHIRA PARVEEN, SAIDA HAIDER AND DARAKHSHAN JABEEN HALEEM
More informationEffects of Systemic Administration of 8-OH-DPAT on Agonistic Social Behaviors in Male Syrian Hamsters
Georgia State University ScholarWorks @ Georgia State University Neuroscience Honors Theses Neuroscience Institute Spring 5-5-2017 Effects of Systemic Administration of 8-OH-DPAT on Agonistic Social Behaviors
More informationStudy Guide Unit 3 Psych 2022, Fall 2003
Psychological Disorders: General Study Guide Unit 3 Psych 2022, Fall 2003 1. What are psychological disorders? 2. What was the main treatment for some psychological disorders prior to the 1950 s? 3. What
More informationAn evaluation of the effect of NAS-181, a new selective 5-HT 1B receptor antagonist, on extracellular 5-HT levels in rat frontal cortex
57 CHAPTER 5 An evaluation of the effect of NAS-181, a new selective 5-HT 1B receptor antagonist, on extracellular 5-HT levels in rat frontal cortex Lotte de Groote, André A. Klompmakers, Berend Olivier,
More informationAcute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers
Psychopharmacology (1999) 146:194 198 Springer-Verlag 1999 ORIGINAL INVESTIGATION Richard J. Porter R. Hamish McAllister-Williams Allan H. Young Acute effects of venlafaxine and paroxetine on serotonergic
More informationNeurotransmitter Functioning In Major Depressive Disorder
Neurotransmitter Functioning In Major Depressive Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. 2017 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD January
More informationAnxiolytic-like effects observed in rats exposed to the elevated zeromaze following treatment with 5-HT2/5-HT3/5-HT4 ligands
Anxiolytic-like effects observed in rats exposed to the elevated zeromaze following treatment with 5-HT2/5-HT3/5-HT4 ligands Bell, R., Duke, A. A., Gilmore, P. E., Page, D., & Bèque, L. (2014). Anxiolytic-like
More informationprocesses in the central nervous system (CNS), affecting many of the during the course of ethanol treatment. Ethanol stimulates the release of
INTRODUCTION INTRODUCTION Neuroscience research is essential for understanding the biological basis of ethanol-related brain alterations and for identifying the molecular targets for therapeutic compounds
More informationNEUROPSYCHOPHARMACOLOGY 2000 VOL. 22, NO American College of Neuropsychopharmacology
Multiple 5-HT Receptors in Passive Avoidance: Comparative Studies of p-chloroamphetamine and 8-OH-DPAT Ilga Misane, Ph.D., and Sven Ove Ögren, Dr. Med.Sc. The aim of this study was to examine the involvement
More informationA brain microdialysis study on 5-HT release in freely moving rat lines selectively bred for differential 5-HT 1A receptor function
Brazilian Journal of Medical and Biological Research (3) 36: 63-67 Serotonin and 5-HT 1A rat lines ISSN 1-879X 63 A brain microdialysis study on 5-HT release in freely moving rat lines selectively bred
More informationEvaluation of Anxiolytic Effect of XXX in Guinea Pig Maternal Separation Test.
Evaluation of Anxiolytic Effect of XXX in Guinea Pig Maternal Separation Test. DATE This study was conducted under terms of a Services Agreement between NeuroDetective Inc. and CLIENT, entitled TITLE OF
More informationANTAGONISM OF APOMORPHINE-INDUCED CAGE CLIMBING BEHAVIOUR AND METHAMPHETAMINE STEREOTYPY BY FENFLURAMINE IN MICE
SHORT COMMUNICATION ANTAGONISM OF APOMORPHINE-INDUCED CAGE CLIMBING BEHAVIOUR AND METHAMPHETAMINE STEREOTYPY BY FENFLURAMINE IN MICE V. P. GADA. V. V. JOSHI. J. J. BALSARA AND A. G. CHANDORKAR Department
More informationΝευροφυσιολογία και Αισθήσεις
Biomedical Imaging & Applied Optics University of Cyprus Νευροφυσιολογία και Αισθήσεις Διάλεξη 19 Ψυχασθένειες (Mental Illness) Introduction Neurology Branch of medicine concerned with the diagnosis and
More informationD. K. RAAP, S. EVANS, F. GARCIA, Q. LI, N. A. MUMA, W. A. WOLF, G. BATTAGLIA and L. D. VAN DE KAR
0022-3565/99/2881-0098$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 288, No. 1 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in
More informationNEUROPSYCHOPHARMACOLOGY 1999 VOL. 21, NO. 2S 1999 American College of Neuropsychopharmacology
Serotonin and Drug-Induced Therapeutic Responses in Major Depression, Obsessive Compulsive and Panic Disorders Pierre Blier, M.D., Ph.D. and Claude de Montigny, M.D., Ph.D. The therapeutic effectiveness
More informationAntidepressant- and anxiogenic-like effects of acute 5-HT 2C receptor activation in rats exposed to the forced swim test and elevated plus maze
PSYCHOLOGY NEUROSCIENCE Psychology & Neuroscience, 2010, 3, 2, 245-249 DOI: 10.3922/j.psns.2010.2.014 Antidepressant- and anxiogenic-like effects of acute 5-HT 2C activation in rats exposed to the forced
More informationFluoxetine-induced anxiety and nervousness
Pharmacological Reports 6, 58, 5 9 ISSN 734-4 Copyright 6 by Institute of Pharmacology Polish Academy of Sciences Short communication Fluoxetine-induced anxiety and nervousness Ma³gorzata Zienowicz, Aleksandra
More informationARTICLE IN PRESS. Available at journal homepage:
Psychoneuroendocrinology (2007) 32, 411 416 Available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/psyneuen SHORT COMMUNICATION Effects of citalopram treatment on hypothermic and
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Age as factor in selective mutism, 623 as factor in social phobia, 623 Agoraphobia, 593 600 described, 594 596 DSM-V changes related to,
More informationAdolescent Prozac Exposure Enhances Sensitivity to Cocaine in Adulthood INTRODUCTION
INTRODUCTION Epidemiologic reports indicate that mood disorders in children and adolescents are quite common, with up to 70% of depressed children and adolescents experiencing a recurrence within 5 years
More informationCitalopram challenge in social anxiety disorder
International Journal of Neuropsychopharmacology (2004), 7, 177 182. Copyright f 2004 CINP DOI: 10.1017/S146114570300405X Citalopram challenge in social anxiety disorder Jakov Shlik, Eduard Maron, Innar
More informationOrientation for New Child and Adolescent Psychiatry Residents: Module Four Pediatric Psychopharmacology
Orientation for New Child and Adolescent Psychiatry Residents: Module Four Pediatric Psychopharmacology Objective: To discuss basic principles of psychopharmacology in children and adolescents. Pharmacokinetics:
More informationNeurochemistry. Dr. Radwan Banimustafa
Neurochemistry Dr. Radwan Banimustafa Introduction Neurochemistry is the study of chemical inter-neuronal communication. Wilhelm and Santiago in the late 19 th century stated that the brain consists of
More informationEffects of chronic paroxetine treatment on dialysate serotonin in 5-HT 1B receptor knockout mice
Journal of Neurochemistry, 2003, 86, 13 24 doi:10.1046/j.1471-4159.2003.01827.x Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT 1B receptor knockout mice A. M. Gardier,* D. J. David,*,
More informationChemical Control of Behavior and Brain 1 of 9
Chemical Control of Behavior and Brain 1 of 9 I) INTRO A) Nervous system discussed so far 1) Specific 2) Fast B) Other systems extended in space and time 1) Nonspecific 2) Slow C) Three components that
More informationBasics of Pharmacology
Basics of Pharmacology Pekka Rauhala Transmed 2013 What is pharmacology? Pharmacology may be defined as the study of the effects of drugs on the function of living systems Pharmacodynamics The mechanism(s)
More informationEffect of Vagus Nerve Stimulation on Serotonergic and Noradrenergic Transmission
0022-3565/06/3182-890 898$20.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 318, No. 2 Copyright 2006 by The American Society for Pharmacology and Experimental Therapeutics 104166/3127272
More informationSustained pharmacological blockade of NK 1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice
Journal of Neurochemistry, 25, 95, 1713 1723 doi:1.1111/j.1471-4159.25.3488.x Sustained pharmacological blockade of NK 1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A
More informationThe relationship between anxiety and depression in animal models: a study using the forced swimming test and elevated plus-maze
Brazilian Correlation Journal between of Medical plus-maze and and Biological forced Research swimming (1999) behaviors 32: 1121-1126 ISSN 0100-879X Short Communication 1121 The relationship between anxiety
More informationdoi: /j x
Journal of Neurochemistry, 2004, 89, 54 63 doi:10.1046/j.1471-4159.2003.02304.x Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin
More informationNEUROPSYCHOPHARMACOLOGY 1997 VOL. 17, NO American College of Neuropsychopharmacology
Fluoxetine, but not Tricyclic Antidepressants, Potentiates the 5-Hydroxytryptophan-Mediated Increase in Plasma Cortisol and Prolactin Secretion in Subjects with Major Depression or with Obsessive Compulsive
More informationNeurochemistry of psychiatric disorders. Dr. Radwan Banimustafa
Neurochemistry of psychiatric disorders Dr. Radwan Banimustafa Introduction Neurochemistry is the study of chemical interneuronal communication. Wilhelm and Santiago in the late 19 th century stated that
More informationNeural Communication. Central Nervous System Peripheral Nervous System. Communication in the Nervous System. 4 Common Components of a Neuron
Neural Communication Overview of CNS / PNS Electrical Signaling Chemical Signaling Central Nervous System Peripheral Nervous System Somatic = sensory & motor Autonomic = arousal state Parasympathetic =
More informationNeurotransmitter Systems I Identification and Distribution. Reading: BCP Chapter 6
Neurotransmitter Systems I Identification and Distribution Reading: BCP Chapter 6 Neurotransmitter Systems Normal function of the human brain requires an orderly set of chemical reactions. Some of the
More informationPHARMACOLOGY Vol. I - Neuropsychopharmacology - Mirjam A.F.M. Gerrits and Jan M. van Ree
NEUROPSYCHOPHARMACOLOGY Mirjam A.F.M. Gerrits and Jan M. van Ree Rudolf Magnus Institute of Neuroscience, Department of Neuroscience and Pharmacology, Universiteitsweg 100, 3584 CG Utrecht, The Netherlands
More informationReview of Neurochemistry What are neurotransmitters?
Review of Neurochemistry What are neurotransmitters? In molecular terms, neurotransmitters are molecules that ( ) and of neurons by, for example, increasing or decreasing enzymatic activity or altering
More informationORAL ADMINISTRATION OF PHYTOLACCA BACCIS (POKE ROOT) EXTRACT INCREASES BRAIN SEROTONIN METABOLISM AND DECREASES FOOD INTAKE IN RATS
Pak. J. Bot., 38(3): 745-75, 26. ORAL ADMINISTRATION OF PHYTOLACCA BACCIS (POKE ROOT) EXTRACT INCREASES BRAIN SEROTONIN METABOLISM AND DECREASES FOOD INTAKE IN RATS SAIDA HAIDER, MISBAH ROOHI, SAIMA KHALIQ,
More informationNeurophysiology and Neurochemistry in PsychoGeriatrics
Tel Aviv University Sackler Faculty of Medicine CME in Psychiatry Neurophysiology and Neurochemistry in PsychoGeriatrics Nicola Maggio, MD, PhD Sackler Faculty of Medicine Tel Aviv University Department
More informationPHYSIOLOGY AND MAINTENANCE Vol. III - Glucocorticoids and Brain - Natalia E. Ordyan and Vera G. Shalyapina
GLUCOCORTICOIDS AND BRAIN Natalia E. Ordyan and Vera G. Shalyapina Pavlov Institute of Physiology, Russian Academy of Sciences, St.-Petersburg, Russia. Keywords: Adaptation, hypothalamic-pituitary-adrenal
More informationEffects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT 1A receptors
British Journal of Pharmacology (2004) 142, 469 478 & 2004 Nature Publishing Group All rights reserved 0007 1188/04 $30.00 www.nature.com/bjp Effects of chronic treatment with escitalopram or citalopram
More informationGuilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.
1-800-PSYCH If you are obsessive-compulsive, dial 1 repeatedly If you are paranoid-delusional, dial 2 and wait, your call is being traced If you are schizophrenic, a little voice will tell you what number
More informationFinal Exam PSYC2022. Fall (1 point) True or False. The DSM-IV describes the symptoms of acute intoxication with cannabis.
Final Exam PSYC2022 Fall 1998 (2 points) Give 2 reasons why it is important for psychological disorders to be accurately diagnosed. (1 point) True or False. The DSM-IV describes the symptoms of acute intoxication
More informationNa + /Cl - -dependent Neurotransmitter Transporters. Outline. Synaptic Transmission. How did the neurotransmitter cross the membrane?
Na /Cl - -dependent Neurotransmitter Transporters Stine Meinild Lundby The Neurobiology Group Molecular, Cellular, and Integrative Physiology Section November 26 th, 2007 slide 1 Outline Synaptic neurotransmission
More informationMale Sexual Dysfunction in Psychiatric Illnesses Sujit Kumar Kar 1, Saranya Dhanasekaran 1 Correspondence: gmail.
RESEARCH ARTICLE Open Access Male Sexual Dysfunction in Psychiatric Illnesses Sujit Kumar Kar 1, Saranya Dhanasekaran 1 Correspondence: drsujita@gmail.com; saranya296@ gmail.com Full list of author information
More informationPatrick Osei-Owusu, Amy James, James Crane, and Karie E. Scrogin
0022-3565/05/3133-1324 1330$20.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 313, No. 3 Copyright 2005 by The American Society for Pharmacology and Experimental Therapeutics 82073/1199553
More informationOrganization of the nervous system. [See Fig. 48.1]
Nervous System [Note: This is the text version of this lecture file. To make the lecture notes downloadable over a slow connection (e.g. modem) the figures have been replaced with figure numbers as found
More informationProf. Anagnostaras, Lecture 7: Fear
Historical views that thought and emotion were processed separately in the brain Prof. Anagnostaras, Lecture 7: So far, fear is the best understood What is fear? Dictionary: A feeling of agitation and
More informationSAMPLE EXAMINATION QUESTIONS
SAMPLE EXAMINATION QUESTIONS PLEASE NOTE, THE QUESTIONS BELOW SAMPLE THE ENTIRE LECTURE COURSE AND THEREORE INCLUDE QUESTIONS ABOUT TOPICS THAT WE HAVE NOT YET COVERED IN CLASS. 1. Which of the following
More informationNeurotransmitter Systems III Neurochemistry. Reading: BCP Chapter 6
Neurotransmitter Systems III Neurochemistry Reading: BCP Chapter 6 Neurotransmitter Systems Normal function of the human brain requires an orderly set of chemical reactions. Some of the most important
More informationThe Neurobiology of Mood Disorders
The Neurobiology of Mood Disorders J. John Mann, MD Professor of Psychiatry and Radiology Columbia University Chief, Department of Neuroscience, New York State Psychiatric Institute Mood Disorders are
More information- Neurotransmitters Of The Brain -
- Neurotransmitters Of The Brain - INTRODUCTION Synapsis: a specialized connection between two neurons that permits the transmission of signals in a one-way fashion (presynaptic postsynaptic). Types of
More informationDog Behaviour Science Lesson 4 Pharmacology
Dog Behaviour Science Lesson 4 Pharmacology Introduction This lesson will take an in depth look at the role the pharmacology plays in behaviour modification. This I an advanced topic that should only be
More informationAngelo Nacca, 1 Giovanna Guiso, 1 Claudia Fracasso, 1 Luigi Cervo & 1,2 Silvio Caccia. Introduction
British Journal of Pharmacology (1998) 125, 1617 1623 ã 1998 Stockton Press All rights reserved 0007 1188/98 $12.00 http://www.stockton-press.co.uk/bjp Brain-to-blood partition and in vivo inhibition of
More informationHISTAMINE INHIBITS EATING WITHOUT ALTERING POSTPRANDIAL SATIETY IN RATS KELLY TSCHANTZ
HISTAMINE INHIBITS EATING WITHOUT ALTERING POSTPRANDIAL SATIETY IN RATS KELLY TSCHANTZ Abstract Exogenous histamine decreases food intake and injection of H-1 antagonists increases food intake in rats.
More informationNeuron types and Neurotransmitters
Neuron types and Neurotransmitters Faisal I. Mohammed. PhD, MD University of Jordan 1 Transmission of Receptor Information to the Brain the larger the nerve fiber diameter the faster the rate of transmission
More informationSubconvulsive Dose of Kainic Acid Transiently Increases the Locomotor Activity of Adult Wistar Rats
Physiol. Res. 64: 263-267, 2015 SHORT COMMUNICATION Subconvulsive Dose of Kainic Acid Transiently Increases the Locomotor Activity of Adult Wistar Rats V. RILJAK 1, D. MAREŠOVÁ 1, J. POKORNÝ 1, K. JANDOVÁ
More informationCentral Neurocircuitry Functioning during the Wake-Sleep Cycle
Chapter 1 OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Central Neurocircuitry Functioning during the Wake-Sleep Cycle The
More informationAN EXPERIMENTAL MODEL OF ALCOHOL-INDUCED ANXIETY AND DEPRESSIVE BEHAVIOUR IN RATS
ORIGINAL ARTICLES AN EXPERIMENTAL MODEL OF ALCOHOL-INDUCED ANXIETY AND DEPRESSIVE BEHAVIOUR IN RATS Stefka Valcheva-Kuzmanova 1, Miroslav Eftimov 1, Krasimir Kuzmanov 2 ABSTRACT 1 Department of Preclinical
More informationSustained Administration of Trazodone Enhances Serotonergic Neurotransmission: In Vivo Electrophysiological Study in the Rat Brain
0022-3565/10/3351-197 206$20.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 335, No. 1 Copyright 2010 by The American Society for Pharmacology and Experimental Therapeutics 169417/3627703
More informationThe Nervous System. Chapter 4. Neuron 3/9/ Components of the Nervous System
Chapter 4 The Nervous System 1. Components of the Nervous System a. Nerve cells (neurons) Analyze and transmit information Over 100 billion neurons in system Four defined regions Cell body Dendrites Axon
More informationNeurotransmitters acting on G-protein coupled receptors
Neurotransmitters acting on G-protein coupled receptors Part 2: Serotonin and Histamine BIOGENIC AMINES Monoamines Diamine Indolamines: Serotonin Basic Neurochemistry. FIGURE 15-1: Chemical structure of
More informationCitation for published version (APA): Tanke, M. A. C. (2009). Serotonin, cortisol, and stress-related psychopathology: from bench to bed s.n.
University of Groningen Serotonin, cortisol, and stress-related psychopathology Tanke, Marit Aline Christine IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you
More informationEffect of combined treatment with mirtazapine and risperidone on the MK-801-induced changes in the object recognition test in mice
Pharmacological Reports 2013, 65, 1401 1406 ISSN 1734-1140 Copyright 2013 by Institute of Pharmacology Polish Academy of Sciences Short communication Effect of combined treatment with mirtazapine and risperidone
More informationEffects of m-cpp and mesulergine on dietary choices in deprived rats: Possible mechanisms of their action
Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 (2006) 112 119 www.elsevier.com/locate/pnpbp Effects of m-cpp and mesulergine on dietary choices in deprived rats: Possible mechanisms of
More informationInvestigation of the role of nesfatin-1/nucb2 in the central nervous system. Ph.D. thesis Katalin Könczöl
Investigation of the role of nesfatin-1/nucb2 in the central nervous system Ph.D. thesis Katalin Könczöl Semmelweis University János Szentágothai Doctoral School of Neurosciences Supervisor: Official reviewers:
More informationThe brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis
Brazilian Journal of Medical and Biological Research (2001) 34: 145-154 Panic or anxiety? ISSN 0100-879X 145 The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis
More informationSerotonin modulates sensitivity to reward and negative. feedback in a probabilistic reversal learning task in rats
Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats Bari A 1,3, Theobald DE 1, Caprioli D 1, Mar AC 1, Aidoo-Micah A 1, Dalley JW 1,2, Robbins
More informationEffect of concomitant administration of three different antidepressants with vitamin B6 on depression and obsessive compulsive disorder in mice models
Research in Pharmaceutical Sciences, February 217; 12(1): 46-52 Received: April 216 Accepted: August 216 School of Pharmacy & Pharmaceutical Sciences Isfahan University of Medical Sciences Original Article
More informationPsychobiology Handout
Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are
More informationPLEASE SCROLL DOWN FOR ARTICLE
This article was downloaded by: [University of Texas Austin] On: 22 June 2009 Access details: Access Details: [subscription number 907743875] Publisher Routledge Informa Ltd Registered in England and Wales
More information10/27/09! Psychopharmacology 101 for the LADC! Disclosures! Lecture outline! Structural divisions of the nervous system!
Disclosures! Psychopharmacology 101 for the LADC! David A. Frenz, M.D.! Mental Health & Addiction Services! St. Josephʼs Hospital! I am employed by the HealthEast Care System! I do not have any financial
More informationIntroduction ORIGINAL INVESTIGATION. K.J. Stanhope C.T. Dourish
Psychopharmacology (1996) 128 : 293 303 Springer-Verlag 1996 ORIGINAL INVESTIGATION K.J. Stanhope C.T. Dourish Effects of 5-HT 1A receptor agonists, partial agonists and a silent antagonist on the performance
More informationNEUROBIOLOGY ALCOHOLISM
NEUROBIOLOGY ALCOHOLISM THERE HAS BEEN A MAJOR THEORETICAL SHIFT IN MEDICATION DEVELOPMENT IN ALCOHOLISM Driven by animal models of intermittent ethanol administration followed by termination, then access
More informationEndocrine system. General principle of endocrinology. Mode of hormone delivery to target. Mode of hormone delivery to target
Endocrine system General principle of endocrinology Co-ordinating system to regulate and integrate function of different cells - Nervous system -Endocrine system Neuro-endocrine system Hormone Molecules
More informationNeurochemistry 2. Loewi s experiment
Neurochemistry 2 Loewi s experiment Cengage Learning 2016 AP reaches the axon terminal and activates voltage-gated Ca++ channels (3 major classes). Ca++ influx results in exocytosis of neurotransmitters
More informationLong-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT 1A Receptors
The Journal of Neuroscience, December 1, 1998, 18(23):10150 10156 Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT 1A Receptors Nasser Haddjeri, Pierre Blier, and Claude
More informationNEW STRATEGIES FOR THE TREATMENT OF MOOD DISORDERS: THE TRIPLE REUPTAKE INHIBITORS
Send Orders for Reprints to reprints@benthamscience.net 234 Neurobiology of Mood Disorders, 2013, 234-253 NEW STRATEGIES FOR THE TREATMENT OF MOOD DISORDERS: THE TRIPLE REUPTAKE INHIBITORS GAËL QUESSEVEUR,
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationADHD Medications & How They Work. Gail C. Rodin, Ph.D. January 21, 2008
ADHD Medications & How They Work Gail C. Rodin, Ph.D. January 21, 2008 Agenda How the (ADHD) Brain Works (or doesn t) Neurons and neurotransmitters NE & DA: the major players in ADHD Channel vs. state
More informationLesson 14. The Nervous System. Introduction to Life Processes - SCI 102 1
Lesson 14 The Nervous System Introduction to Life Processes - SCI 102 1 Structures and Functions of Nerve Cells The nervous system has two principal cell types: Neurons (nerve cells) Glia The functions
More informationTITLE: The STRONG STAR Multidisciplinary PTSD Research Consortium
AD Award Number: W81XWH-08-2-0118 TITLE: The STRONG STAR Multidisciplinary PTSD Research Consortium PRINCIPAL INVESTIGATOR: Randy Strong. Ph.D. Alan Frazer, Ph.D. David Morilak, Ph.D. CONTRACTING ORGANIZATION:
More information1 Presynaptic adaptive responses to constitutive versus adult pharmacologic inhibition of serotonin uptake
beth a. luellen, tracy l. gilman and anne milasincic andrews 1 Presynaptic adaptive responses to constitutive versus adult pharmacologic inhibition of serotonin uptake abstract Many antidepressants are
More informationPharmacological treatment of anxiety disorders where is
Pharmacological treatment of anxiety disorders where is the room for improvement? David S Baldwin, Professor of Psychiatry BAP Masterclass, 15 th April 2011 dsb1@soton.ac.uk Declaration of interests (last
More informationEVALUATION OF ANTIDEPRESSANT ACTIVITY OF ONDANSETRON IN ALBINO MICE
EVALUATION OF ANTIDEPRESSANT ACTIVITY OF ONDANSETRON IN ALBINO MICE *Janardhan M. 1, Anil kumar G. 1 and Naveen Kumar T. 2 1 Department of Pharmacology, Kamineni Institute of Medical Sciences and Research,
More informationANTIDEPRESSANT AUGMENTATION WITH BUSPIRONE: EFFECTS ON SEIZURE THRESHOLD AND BRAIN SEROTONIN LEVELS IN MICE
Indian Journal of Pharmacology 2001; 33: 198-202 RESEARCH PAPER ANTIDEPRESSANT AUGMENTATION WITH BUSPIRONE: EFFECTS ON SEIZURE THRESHOLD AND BRAIN SEROTONIN LEVELS IN MICE KHANAM RAZIA, M.A.A. SIDDIQUI,
More informationInterest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review
doi: 10.1111/j.1472-8206.2008.00640.x REVIEW ARTICLE Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review Alain M. Gardier*, Bruno
More information